Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry J Duff

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|October 9, 2007
Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmiasJianmin Xiao, Xixi Tian, Peter P Jones, et al.
The Biochemical Journal|September 2, 2016
Suppression of ryanodine receptor function prolongs Ca2+ release refractoriness and promotes cardiac alternans in intact heartsXiaowei Zhong, Bo Sun, Alexander Vallmitjana, et al.
Journal of Chemical Information and Modeling|August 23, 2021
Toward Reducing hERG Affinities for DAT Inhibitors with a Combined Machine Learning and Molecular Modeling ApproachKuo Hao Lee, Andrew D Fant, Jiqing Guo, et al.
ACS Pharmacology & Translational Science|February 15, 2024
Series of (([1,1'-Biphenyl]-2-yl)methyl)sulfinylalkyl Alicyclic Amines as Novel and High Affinity Atypical Dopamine Transporter Inhibitors with Reduced hERG ActivityTherese C Ku, Jianjing Cao, Sung Joon Won, et al.
Experimental Physiology|August 1, 2012
The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1βNathan A Bracey, Paul L Beck, Daniel A Muruve, et al.
Circulation Research|July 17, 2013
Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in miceYunlong Bai, Peter P Jones, Jiqing Guo, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 26, 2019
Mutations in ILK, encoding integrin-linked kinase, are associated with arrhythmogenic cardiomyopathyAndreas Brodehl, Saman Rezazadeh, Tatjana Williams, et al.
Molecular Metabolism|December 24, 2023
Mutations in DNAJC19 cause altered mitochondrial structure and increased mitochondrial respiration in human iPSC-derived cardiomyocytesAnna Janz, Katharina Walz, Alexandra Cirnu, et al.
Journal of the American College of Cardiology|December 11, 2007
Noninvasive risk assessment early after a myocardial infarction the REFINE studyDerek V Exner, Katherine M Kavanagh, Michael P Slawnych, et al.
The Canadian Journal of Cardiology|December 16, 2019
Direct Effects of Empagliflozin on Extracellular Matrix Remodelling in Human Cardiac Myofibroblasts: Novel Translational Clues to Explain EMPA-REG OUTCOME ResultsSean Kang, Subodh Verma, Ali Fatehi Hassanabad, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|October 9, 2007
Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmiasJianmin Xiao, Xixi Tian, Peter P Jones, et al.
The Biochemical Journal|September 2, 2016
Suppression of ryanodine receptor function prolongs Ca2+ release refractoriness and promotes cardiac alternans in intact heartsXiaowei Zhong, Bo Sun, Alexander Vallmitjana, et al.
Journal of Chemical Information and Modeling|August 23, 2021
Toward Reducing hERG Affinities for DAT Inhibitors with a Combined Machine Learning and Molecular Modeling ApproachKuo Hao Lee, Andrew D Fant, Jiqing Guo, et al.
ACS Pharmacology & Translational Science|February 15, 2024
Series of (([1,1'-Biphenyl]-2-yl)methyl)sulfinylalkyl Alicyclic Amines as Novel and High Affinity Atypical Dopamine Transporter Inhibitors with Reduced hERG ActivityTherese C Ku, Jianjing Cao, Sung Joon Won, et al.
Experimental Physiology|August 1, 2012
The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1βNathan A Bracey, Paul L Beck, Daniel A Muruve, et al.
Circulation Research|July 17, 2013
Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in miceYunlong Bai, Peter P Jones, Jiqing Guo, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 26, 2019
Mutations in ILK, encoding integrin-linked kinase, are associated with arrhythmogenic cardiomyopathyAndreas Brodehl, Saman Rezazadeh, Tatjana Williams, et al.
Molecular Metabolism|December 24, 2023
Mutations in DNAJC19 cause altered mitochondrial structure and increased mitochondrial respiration in human iPSC-derived cardiomyocytesAnna Janz, Katharina Walz, Alexandra Cirnu, et al.
Journal of the American College of Cardiology|December 11, 2007
Noninvasive risk assessment early after a myocardial infarction the REFINE studyDerek V Exner, Katherine M Kavanagh, Michael P Slawnych, et al.
The Canadian Journal of Cardiology|December 16, 2019
Direct Effects of Empagliflozin on Extracellular Matrix Remodelling in Human Cardiac Myofibroblasts: Novel Translational Clues to Explain EMPA-REG OUTCOME ResultsSean Kang, Subodh Verma, Ali Fatehi Hassanabad, et al.
Pageof 8